University of Wisconsin, Madison

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).

1,039 total trials 151 currently recruiting 712 completed early-phase tilt top decile by trial count

University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.

University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.

Top-decile sponsor footprint

University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 56/100

712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,039 total, page 13 of 21

COMPLETED Phase 1

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

NCT02411786

COMPLETED

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

NCT02025543

COMPLETED Phase 3

Prevention of Post-operative Urinary Retention

NCT02486653

COMPLETED NA

Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer

NCT02470897

COMPLETED Phase 1

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

NCT02499835

COMPLETED NA

Educational Intervention for Reducing Work Disability in Breast Cancer Survivors

NCT01799031

COMPLETED NA

Brain Changes With Game Training in Aging

NCT02490137

TERMINATED Phase 1

Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy

NCT02434146

COMPLETED NA

Adductor Canal Block for Total Knee Arthroplasty

NCT02453360

COMPLETED NA

aeRobic Exercise and Cognitive Health

NCT02384993

COMPLETED Phase 4

Stress Neuroadaptation in Tobacco Dependence

NCT03262233

COMPLETED

Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients

NCT02434133

COMPLETED Phase 3

Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery

NCT02423876

COMPLETED

Intraoperative Anaesthesia Awareness Following Induction of Anaesthesia

NCT02248623

COMPLETED NA

The Effectiveness of Peer-to-Peer Community Support to Promote Aging in Place

NCT02308696

COMPLETED NA

Motor Learning and Brain Changes in Autism

NCT02358317

COMPLETED NA

A Trial of the C-TraC Intervention for Dementia Patients

NCT02388711

COMPLETED NA

Parent Communication for Feeding an Infant With a Heart Defect

NCT04452201

COMPLETED

Improving Muscle Assessment in Older Adults - The "Can We Build a Better Mouse Trap?" Study

NCT02295241

COMPLETED NA

The Utility of Pretracheal Stethoscope in Detecting Respiratory Abnormalities in Sedated Children

NCT01957566

COMPLETED NA

Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk

NCT02404701

COMPLETED

Project 1: Evaluating EHR-Based Health System Modifications for the Chronic Care of Smoking

NCT02358330

COMPLETED Phase 2

Bevacizumab Against Recurrent Retinal Detachment

NCT02192970

COMPLETED NA

Effects of Oropharyngeal Strengthening on Dysphagia in Patients Post-stroke

NCT02322411

COMPLETED Phase 4

A Comparative Effectiveness RCT of Optimized Cessation Treatments

NCT02301403

COMPLETED Phase 4

Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit

NCT02354872

COMPLETED

Global Iliac Branch Study

NCT05607277

COMPLETED NA

Brief Trainings to Buffer Against Acute Stress Effects

NCT02214264

COMPLETED NA

A Quit Smoking Study Using Smartphones

NCT02164383

COMPLETED NA

Influence of Lifestyle Factors on Neutrophil Migration Pilot Study

NCT02411318

COMPLETED

Brain-Gut Interactions in Crohn's Disease

NCT02108938

COMPLETED NA

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

NCT02096783

COMPLETED Phase 4

VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)

NCT02268500

COMPLETED NA

Tailored Diabetes Self-Management Resources

NCT02024750

COMPLETED Phase 1

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

NCT02146222

COMPLETED NA

Wisconsin Center for the Neuroscience and Psychophysiology of Meditation

NCT02157766

TERMINATED NA

Microwave Coagulation in Partial Nephrectomy Protocol

NCT01931462

COMPLETED NA

Effects of Vocal Exercises for Spasmodic Dysphonia

NCT03349086

COMPLETED

Physician Coaching to Reduce Opioid-related Harms

NCT02433496

COMPLETED NA

Validation of the Wisconsin Stone-QOL

NCT02188108

COMPLETED Phase 2

Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer

NCT02138214

COMPLETED NA

Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

NCT02967315

TERMINATED

Identification of Donor Specific B Cells and Antibody Mediated Rejection

NCT02133248

COMPLETED

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

NCT02171078

COMPLETED Phase 1

UW Psilocybin Pharmacokinetics Study

NCT02163707

COMPLETED NA

Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury

NCT02158494

COMPLETED Phase 1

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

NCT01918644

COMPLETED NA

Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents

NCT02116192

COMPLETED NA

Yoga's Effect on Fall Risk Factors in the Rural, Older Adult Population; an Academic/Community Partnership

NCT02443038

COMPLETED

Fetal and Neonatal Magnetophysiology

NCT01903564

← Previous Page 13 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 109
Phase 2 142
Phase 3 19
Phase 4 79

What is open in the University of Wisconsin, Madison pipeline

151 recruiting of 1,039 indexed (15% open); 712 completed (69%).

Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).

Top condition: Healthy (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Wisconsin, Madison: open-pipeline peers nationwide

Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of Wisconsin, MadisonUniversity of WashingtonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillMasonic Cancer Center, University of MinnesotaModernaTXUnited States Naval Medical Center, San DiegoThe Cleveland Clinic
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,039 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this University of Wisconsin, Madison page

1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.

  • 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.